Which blood tests are appropriate for evaluating suspected gluten sensitivity (non‑celiac gluten sensitivity)?

Blood Tests for Non-Celiac Gluten Sensitivity

There are no validated blood tests for diagnosing non-celiac gluten sensitivity (NCGS), and the diagnosis remains clinical based on symptom response to gluten elimination and rechallenge after excluding celiac disease and wheat allergy.

Critical Distinction: NCGS vs. Celiac Disease

The question asks about gluten sensitivity, but the evidence base focuses primarily on celiac disease serology. This is a crucial distinction because:

• NCGS has no specific serological markers 1, 2, 3
• Blood tests are used to rule out celiac disease, not to diagnose NCGS
• The diagnosis of NCGS is one of exclusion

Appropriate Testing Algorithm

Step 1: Rule Out Celiac Disease First

Before considering NCGS, you must exclude celiac disease with the following panel 4, 5:

• Anti-tissue transglutaminase IgA (tTG-IgA) - most important single test
• Total IgA level - essential to identify IgA deficiency
• Anti-deamidated gliadin peptide IgA (DGP-IgA)
• Endomysial antibody IgA (EMA-IgA) - highly specific

If IgA deficient: Use IgG versions of tTG and DGP instead 4, 5

Step 2: Consider HLA-DQ2/DQ8 Testing

• Negative HLA-DQ2/DQ8 effectively rules out celiac disease 4, 5
• Approximately 50% of NCGS patients are DQ2-positive, so this does not diagnose NCGS 6
• Use this test when serology is negative but clinical suspicion for celiac disease remains high

Step 3: Tests That May Be Positive in NCGS (But Are Not Diagnostic)

IgG anti-gliadin antibodies (AGA IgG):

• Positive in 56% of NCGS patients 1
• Also positive in 81% of celiac patients 1
• Specificity of 86.7% but sensitivity only 33.3% for NCGS 7
• Not recommended as a diagnostic tool - lacks adequate sensitivity and specificity

IgA anti-gliadin antibodies (AGA IgA):

• Positive in only 7.7% of NCGS patients 1
• No longer recommended for celiac disease diagnosis 8
• Not useful for NCGS diagnosis

What Tests Are NOT Helpful for NCGS

The following are negative in NCGS and their presence indicates celiac disease instead 1:

• Anti-tissue transglutaminase (tTG)
• Endomysial antibodies (EMA)
• Anti-deamidated gliadin peptide antibodies (DGP)

Clinical Diagnosis of NCGS

Since no blood test diagnoses NCGS, the diagnosis requires 9, 10:

1. Symptoms similar to celiac disease (abdominal pain, bloating, diarrhea, fatigue, brain fog, joint pain)
2. Negative celiac serology (tTG, EMA, DGP all negative)
3. Normal or minimally abnormal duodenal biopsy
4. Negative wheat allergy testing
5. Symptom resolution on gluten-free diet
6. Symptom recurrence with gluten rechallenge

Critical Pitfalls to Avoid

Do not test after starting a gluten-free diet: Patients must be consuming gluten (equivalent to 3 slices of wheat bread daily for 1-3 months) for accurate celiac serology 5. Testing after gluten elimination reduces sensitivity of both serology and biopsy.

Do not rely on AGA testing alone: Despite some positivity in NCGS, AGA IgG has insufficient diagnostic accuracy (33% sensitivity) to be clinically useful 7. The recent 2026 study confirms this limited utility.

Do not skip celiac disease exclusion: The consequences of missing celiac disease (increased mortality, malignancy risk, osteoporosis) far outweigh the inconvenience of thorough testing 4, 5.

Consider alternative diagnoses: Many patients with suspected NCGS may actually have IBS, FODMAP sensitivity, or other disorders of gut-brain interaction 2, 3. Low-FODMAP diets often improve symptoms attributed to NCGS.

Emerging Research Limitations

While some studies suggest potential biomarkers (zonulin, certain cytokines, microRNA) 10, none are validated for clinical use. The ALCAT test and other commercial panels lack evidence-based support 10.

The gluten-free diet industry's growth to $26.5 billion by 2030 2 reflects widespread adoption beyond medical necessity, emphasizing the importance of proper diagnostic evaluation before recommending dietary restriction.